Biomarkers for the treatment of psoriasis

A psoriasis, biological sample technology, applied in biological testing, biological material analysis, drug combination and other directions, can solve the problem of low expression level of anti-inflammatory cytokine IL-10

Active Publication Date: 2013-04-03
AMGEN (EURO) GMBH
View PDF54 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Furthermore, low expression levels of the anti-inflammatory cytokine IL-10 were observed in psoriatic lesions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarkers for the treatment of psoriasis
  • Biomarkers for the treatment of psoriasis
  • Biomarkers for the treatment of psoriasis

Examples

Experimental program
Comparison scheme
Effect test

specific example

[0388] Y is i) phenyl or heterocyclic ring, which is unsubstituted or substituted by one or more substituents each independently selected from the group consisting of nitro, cyano, trifluoromethyl, ethoxycarbonyl, Methoxycarbonyl, propoxycarbonyl, acetyl, carbamoyl, acetoxy, carboxyl, hydroxy, amino, alkyl of 1 to 10 carbon atoms, alkoxy of 1 to 10 carbon atoms, or halogen, or ii) naphthyl. Specific examples of compounds have the formula:

[0389]

[0390] in:

[0391] Ar is 3,4-disubstituted phenyl, wherein each substituent is independently selected from: nitro, cyano, trifluoromethyl, ethoxycarbonyl, methoxycarbonyl, propoxycarbonyl, acetyl, amino formyl, acetoxy, carboxyl, hydroxyl, amino, alkyl of 1 to 10 carbon atoms, alkoxy of 1 to 10 carbon atoms, and halogen;

[0392] Z is alkoxy, benzyloxy, amino or alkylamino of 1 to 10 carbon atoms; and

[0393] Y is (i) unsubstituted phenyl or phenyl substituted by one or more substituents independently selected from the gro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided herein are the biomarkers for predicting or monitoring the efficacy of a treatment for psoriasis. The use of certain cell markers and mRNA levels as biomarkers to predict whether a psoriasis treatment is likely to be successful is also provided. Further, the expression of these genes or cell markers can be used to monitor progress of treatment effectiveness and patient compliance in psoriasis patients who are receiving treatment.

Description

1. Technical field [0001] Provided herein is the monitoring of specific biomarkers in samples obtained from skin biopsies before and during treatment of psoriasis. Also provided herein is monitoring of the expression of one or more specific genes or proteins prior to and during treatment. 2. Background technology [0002] Psoriasis is a chronic autoimmune inflammatory skin disease characterized by epidermal hyperproliferation of keratinocytes and endothelial cells and accumulation of inflammatory cells such as activated T cells. Griffiths CE, J. Eur. Acad. Dermatol. Venereol. 2003, 17 Suppl 2: 1-5; Creamer JD et al., Clin. Exp. Dermatol. 1995, 20(1): 6-9. In addition, recent evidence implicates the involvement of natural killer cells (NK) and NK T cells in the pathogenesis of psoriasis, as these cells produce interferon-γ (IFN-γ), which has been shown to be involved in silver Play a role in the proliferation of psoriatic keratinocytes. Bos JD et al., Br. J. Dermatol. 2005...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/50
CPCG01N2333/70525G01N2333/7051G01N2333/70539G01N2800/205G01N33/5044G01N2333/70596G01N33/5091G01N2800/52A61P17/06A61P17/10G01N33/48
Inventor 彼得·H·谢弗勇·林唐纳·萨瑟兰
Owner AMGEN (EURO) GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap